Moreover, our findings also proved that overexpressed miR-129-5p or silenced ZEB1-AS1 contributed to the decreased expressions of ZEB1, Bcl-2, MDR1, P-gp and ZEB1-AS1, thus reducing drug resistance to cisplatin and enhancing the overall cell apoptosis in breast cancer. This evidence concerns the gene BCL2 and breast cancer.